Clinical trials continue to grow more complex, and many programs struggle with uneven communication, inconsistent workflows and variable site readiness. This whitepaper explores how sponsors, CROs and clinical sites are strengthening productivity by adopting more collaborative models that support smoother trial execution.

Fortrea outlines practices that help teams work together more effectively, showing how aligned stakeholders can reduce delays, improve enrollment and create a more connected and human centered research environment. The guide highlights the real challenges that affect performance, including site specific issues, inefficient workflows, limited site diversity and over reliance on technology. It also examines how thoughtful site selection and tailored productivity initiatives can help teams prioritize improvements that have the greatest impact.

Readers will learn how collaboration improves trial quality and speed by simplifying processes, supporting site staff more effectively and using technology in ways that reduce burden. Additional insights include the importance of strong CRA capabilities, patient training that reflects diverse needs and the use of dry runs to identify operational gaps before they affect real participants.

What you will learn:

  • How open communication and alignment across sponsors, CROs and sites improve trial execution
  • Ways to address site‑specific challenges that limit enrollment, productivity and data quality
  • Approaches to streamline workflows and reduce delays across multi‑site programs
  • How to balance technology with human oversight to support efficiency without adding burden
  • Opportunities to expand beyond traditional research sites for greater diversity and reach
  • Best practices to strengthen CRA effectiveness and site engagement
  • Methods to simplify and prioritize payments to reduce operational bottlenecks
  • The value of “dry runs” to identify issues before they disrupt real trial activity

Read the full whitepaper to understand how collaborative approaches are helping sponsors and CROs improve trial performance, accelerate timelines and support better outcomes.

Access the Whitepaper